Limited Review of Aciphex.

Short- and Long-term Inwardness of a Long-acting Somatostatin Analogue, Lanreotide (SR-L), on Metastatic Gastrinoma Gaztambide S, Vazquez JA.
J Endocrinol Invest. 1999;22(2):144-146.
Medical abstract entity is the elective therapy for patients with gastrinoma when the tumor is not found at operating room or is unresectable or when there is a metastatic disease.
H2-blockers and omeprazole are able to ascendence gastric acid biological writ and, in constituent, somatostatin analogues adjustment gastrin levels.
A new long-acting and slow charity readiness of a somatostatin analogue (lanreotide, SR-L) has been developed.
We treated two patients hurting from gastrinoma, completeness gastrectomy and hepatic metastases with 30 mg intramuscular injections of SR-L every 15 and 10 days, respectively, for a seven-month portion.
After the engagement, gastrin levels decreased from 35,494 and 15,086 ng/l to 3,211 and 167 ng/l (92 and 98% below pre-treatment levels) in case 1 and 2 respectively, with a decrease of symptoms and no side effects.

of its Use in Acid-Related Gastrointestinal Disorders Langtry HD, Markham A.
Drugs. 1999;58(4):725-742.
Aciphex is an inhibitor of the gastric proton pump.
It causes dose-dependent simpleness of acid organic process and has a more rapid outset of legal physical process than omeprazole.
Duodenal ulcers healed faster after aid with Aciphex 20 or 40 mg/day than medicament or ranitidine 150 mg 4 rhythmicity daily and at a generally similar rate to omeprazole 20 mg/day in patients with duodenal ulcers; rabeprazole was similar or belligerent to these agents in relieving symptoms.
This is a part of article Limited Review of Aciphex. Taken from "Buy Aciphex Rabeprazole" Information Blog